Life Long Learning Prep Course: A Focused Review Webcast: Core Urology (2021)

Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.

The purpose of the Life Long Learning Prep Course is to prepare attendees for the ABU knowledge assessment. This course will be practice-focused and will offer practical and clinically-specific updates. It will highlight the AUA guidelines and address general urology practice issues that can be expected on the knowledge assessment. The course will model the ABU exam by covering Core/General Urology on the first day followed by your pre-selected module on the second day.

Sample multiple choice practice questions as well as case-based discussions will be utilized to prepare attendees for the upcoming knowledge assessment. For more information please visit www.abu.org/recertification.

 

Target Audience

  • Urologists

Learning Objectives

Core Urology

At the conclusion of this course, participants will be able to:

  1. Review generally accepted urological practices for superior patient care.
  2. Discuss a core knowledge of urology necessary for taking the Knowledge Assessment.
  3. Examine the most recent changes and additions to the AUA guidelines.

 

Course summary
Course opens: 
06/28/2021
Course expires: 
09/22/2024
Rating: 
0

Life Long Learning Prep Course: A Focused Review

Scientific Program

CORE UROLOGY
Course Directors: Mark L. Gonzalgo, MD & Daniel H. Williams, IV, MD
Saturday, September 18, 2021
9:00 – 9:05 a.m.Welcome
Barbara Schubert
9:05 – 9:15 a.m.Introduction
Mark L. Gonzalgo, MD, PhD & Daniel H. Williams, IV, MD
9:15 – 9:50 a.m.General Cancer 1 (Localized/Advanced Prostate, Localized Kidney)
Mark L. Gonzalgo, MD, PhD
9:50 – 10:00 a.m.Mock Exam Questions
10:00 – 10:35 a.m.General Cancer 2 (Bladder, Upper Tract TCC, Advanced Kidney)
Siamak Daneshmand, MD
10:35 – 10:45 a.m.Mock Exam Questions
10:45 – 11:20 a.m.Complications of Urologic Surgery
Suzanne Merrill, MD, FACS
11:20 – 11:30 a.m.Mock Exam Questions
11:30 – 12:05 p.m.Trauma
Jay Simhan, MD
12:05 – 12:15 p.m.Mock Exam Questions
12:15 – 12:50 p.m.BREAK
12:50 – 1:05 p.m.Endocrine I - Andrology
Daniel H. Williams, IV, MD
1:05 – 1:20 p.m.Endocrine II - Andrology
Sarah L. Elfering, MD
1:20 – 1:30 p.m.Mock Exam Questions
1:30 – 2:05 p.m.Stones (not metabolic stones)
Kevan M. Sternberg, MD
2:05 – 2:15 p.m.Mock Exam Questions
2:15 – 2:50 p.m.Infection
Robert J. Evans, MD, FACS
2:50 – 3:00 p.m.Mock Exam Questions
3:00 – 3:35 p.m.Prostate Evaluation/Biopsy
Suzanne Merrill, MD, FACS
3:35 – 3:45 p.m.Mock Exam Questions
3:45 – 4:20 p.m.Radiology/ Radiation Safety
Robert Marcovich, MD
4:20 – 4:30 p.m.Mock Exam Questions
4:30 – 5:20 p.m.Office Based Practice and Guidelines
Tomas L. Griebling, MD, MPH
5:20 – 5:30 p.m.Mock Exam Questions
Module 1: Oncology, Urinary Diversion and Adrenal
Moderator: Mark L. Gonzalgo, MD, PhD
Sunday, September 19, 2021
8:15 – 8:25 a.m.Welcome
8:25 – 8:55 a.m.ABU Continuing Certification Program
J. Brantley Thrasher, MD, FACS & David B. Joseph, MD, FACS, FAAP
8:55 – 9:05 a.m.Attendees get to Breakout Rooms/Introduction
Mark L. Gonzalgo, MD, PhD
9:05 – 9:45 a.m.Urothelial Bladder Cancer
Siamak Daneshmand, MD
9:45 – 10:20 a.m.Prostate Cancer – Localized
Mark L. Gonzalgo, MD, PhD
10:20 – 10:35 a.m.Live Q&A
10:35 – 11:15 a.m.Testicular Cancer
Chad R. Ritch, MD, MBA
11:15 – 11:55 a.m.Penile/Urethral Cancer
Chad R. Ritch, MD, MBA
11:55 – 12:10 p.m.Live Q&A
12:10 – 12:45 p.m.BREAK
12:45 – 1:30 p.m.Upper Tract Tumors/ Urinary Diversion
Siamak Daneshmand, MD
1:30 – 2:10 p.m.Kidney Cancer
Viraj A. Master, MD, PhD, FACS
2:10 – 2:55 p.m.Live Q&A
2:55 – 3:05 p.m.Adrenal
Viraj A. Master, MD, PhD, FACS
3:05 – 3:45 p.m.Prostate Cancer – Advanced
Mark L. Gonzalgo, MD, PhD
3:45 – 4:00 p.m.Live Q&A
4:00 – 5:00 p.m.Mock Multiple Choice Exam and Review
All Faculty
Module 2: Calculi, Laparoscopy-Robotics and Upper Tract Obstruction
Moderator: Stephen V. Jackman, MD
Sunday, September 19, 2021
8:15 – 8:25 a.m.Welcome
8:25 – 8:55 a.m.ABU Continuing Certification Program
J. Brantley Thrasher, MD, FACS & David B. Joseph, MD, FACS, FAAP
8:55 – 9:10 a.m.Attendees get to Breakout Rooms/Introduction
Stephen V. Jackman, MD
9:10 – 10:00 a.m.Upper Tract Obstruction
Kevan M. Sternberg, MD
10:00 – 10:40 a.m.Ureterolithiasis – Surgical Management of Ureteric Calculi
Robert Marcovich, MD
10:40 – 10:55 a.m.Live Q&A
10:55 – 11:35 a.m.Nephrolithiasis – Surgical Management of Renal Calculi
Kevan M. Sternberg, MD
11:35 – 12:15 p.m.Calculus Disease – Medical Management
Robert Marcovich, MD
12:15 – 12:30 p.m.Live Q&A
12:30 – 1:15 p.m.BREAK
1:15 – 2:15 p.m.Principles of Laparoscopy/Robotics
Stephen V. Jackman, MD
2:15 – 3:15 p.m.Complications of Laparoscopy/Robotics
Stephen V. Jackman, MD
3:15 – 3:30 p.m.Live Q&A
3:30 – 4:30 p.m.Mock Multiple Choice Exam and Review
All Faculty
Module 3: Impotence, Infertility and Andrology
Moderator: Daniel H. Williams, IV, MD
Sunday, September 19, 2021
8:15 – 8:25 a.m.Welcome
8:25 – 8:55 a.m.ABU Continuing Certification Program
J. Brantley Thrasher, MD, FACS & David B. Joseph, MD, FACS, FAAP
8:55 – 9:10 a.m.Attendees get to Breakout Rooms/Introduction
Daniel H. Williams, IV, MD
9:05 – 9:45 a.m.Erectile Dysfunction
Nelson E. Bennett Jr., MD, FACS
9:45 – 10:25 a.m.Ejaculatory Dysfunction
David Shin, MD
10:25 – 10:40 a.m.Live Q&A
10:40 – 11:20 a.m.Male Infertility: Evaluation and Medical Management
Daniel H. Williams, IV, MD
11:20 – 12:00 p.m.Peyronie’s Disease
Nelson E. Bennett Jr., MD, FACS
12:00 – 12:15 p.m.Live Q&A
12:15 – 12:50 p.m.BREAK
12:50 – 1:30 p.m.Andrology
David Shin, MD
1:30 – 2:10 p.m.Male Infertility: Surgical Management
Daniel H. Williams, IV, MD
2:10 – 2:25 p.m.Live Q&A
2:25 – 3:05 p.m.Priapism
Nelson E. Bennett Jr., MD, FACS
3:05 – 3:30 p.m.Vasectomy
David Shin, MD
3:30 – 4:00 p.m.Live Q&A
4:00 – 5:00 p.m.Mock Multiple Choice Exam and Review
All Faculty
Module 4: Office Based Urology
Moderator: Benjamin M. Brucker, MD
Sunday, September 19, 2021
8:15 – 8:25 a.m.Welcome
8:25 – 8:55 a.m.ABU Continuing Certification Program
J. Brantley Thrasher, MD, FACS & David B. Joseph, MD, FACS, FAAP
8:55 – 9:10 a.m.Attendees get to Breakout Rooms/Introduction
Benjamin M. Brucker, MD
9:05 – 9:35 a.m.BPH
Thomas Chi, MD
9:35 – 10:05 a.m.Urethral Strictures-stenosis
John Stoffel, MD
10:05 – 10:20 a.m.Live Q&A
10:20 – 10:50 a.m.LUTS – male and female
Benjamin Brucker, MD
10:50 – 11:20 a.m.Stress Urinary Incontinence (Male and Female)
Benjamin M. Brucker, MD
11:20 – 11:35 a.m.Live Q&A
11:35 – 12:40 p.m.Renal and Urethral CalculiThomas Chi, MD
12:40 – 1:15 p.m.BREAK
1:15 – 2:20 p.m.Neoplasia
Josh Meeks, MD
2:20 – 2:35 p.m.Live Q&A
2:35 – 3:10 p.m.Androgen Deficiency
Joe Alukal, MD
3:10 – 3:45 p.m.Erectile Dysfunction
Joe Alukal, MD
3:45 – 4:00 p.m.Live Q&A
4:00 – 5:00 p.m.Mock Multiple Choice Exam and Review
All Faculty

Education Council Disclosures:

PDF iconEducation Council Disclosures_ June 2021

COI Work Group Disclosures:

PDF iconCOI Review Work Group Disclosures 2021

All relevant financial relationships have been mitigated. 

AUA Office of Education Staff has nothing to disclose.

Course Co-director(s)

Mark Gonzalgo, MD, PHD

has no relevant financial relationships to disclose at this time.

Daniel Williams, MD

has no relevant financial relationships to disclose at this time.
Faculty(s)

Joseph Alukal, MD

has a financial relationship (Consultant or Advisor (Specialty Not Specified)) with Phosphorus;.
has a financial relationship (Consultant or Advisor (Specialty Not Specified)) with Sandstone;.
has a financial relationship (Other (Erectile Dysfunction)) with Endo Pharmaceuticals;.
has a financial relationship (Consultant or Advisor (Specialty Not Specified)) with Ezra;.

Nelson Bennett, MD

has a financial relationship (Meeting Participant or Lecturer (Specialty Not Specified)) with Endo;.

Benjamin Brucker, MD

has a financial relationship (Consultant or Advisor (General Urology)) with Urovant ;.
has a financial relationship (Consultant or Advisor (General Urology)) with Click Theraputics, Inc.;.
has a financial relationship (Consultant or Advisor (General Urology)) with Anteres;.
has a financial relationship (Consultant or Advisor (Specialty Not Specified)) with Allergan;.
has a financial relationship (Consultant or Advisor (Specialty Not Specified)) with Conti Watson ;.

Thomas Chi, MD,MBA

has a financial relationship (Consultant or Advisor (Endourology/Stone Disease)) with Dornier;.
has a financial relationship (Consultant or Advisor (Specialty Not Specified)) with Boston Scientific Corporation;.
has a financial relationship (Consultant or Advisor (Specialty Not Specified)) with Bard Medical;.
has a financial relationship (Leadership Position (Endourology/Stone Disease)) with Perceus;.

Siamak Daneshmand, MD

has a financial relationship (Consultant or Advisor (Oncology)) with Aduro;.
has a financial relationship (Consultant or Advisor (Oncology)) with Johnson and Johnson;.
has a financial relationship (Consultant or Advisor (Oncology)) with Pacific Edge;.
has a financial relationship (Consultant or Advisor (Oncology)) with nucleix;.
has a financial relationship (Consultant or Advisor (Oncology)) with Ferring;.
has a financial relationship (Consultant or Advisor (Oncology)) with Abbvie;.
has a financial relationship (Consultant or Advisor (Oncology)) with QED;.
has a financial relationship (Consultant or Advisor (Oncology)) with Seattle Genetics;.
has a financial relationship (Consultant or Advisor (Oncology)) with BMS;.
has a financial relationship (Consultant or Advisor (Oncology)) with Photocure;.

Sarah Elfering, MD

has no relevant financial relationships to disclose at this time.

Robert Evans, MD,FACS

has a financial relationship (Investment Interest (Specialty Not Specified)) with urigen;.

Tomas Griebling, MD, MPH

has no relevant financial relationships to disclose at this time.

Stephen Jackman, MD

has no relevant financial relationships to disclose at this time.

Robert Marcovich, MD

has no relevant financial relationships to disclose at this time.

Viraj Master, MD, PHD

has no relevant financial relationships to disclose at this time.

Joshua Meeks, MD, PHD

has a financial relationship (Meeting Participant or Lecturer (Oncology)) with Olympus;.
has a financial relationship (Consultant or Advisor (Specialty Not Specified)) with Ferring;.
has a financial relationship (Consultant or Advisor (Oncology)) with bristol myers squibb;.
has a financial relationship (Consultant or Advisor (Specialty Not Specified)) with AstraZeneca;.
has a financial relationship (Consultant or Advisor (Oncology)) with Nucleix;.
has a financial relationship (Consultant or Advisor (Oncology)) with foundation medicine;.
has a financial relationship (Consultant or Advisor (Oncology)) with Jansen;.
has a financial relationship (Scientific Study or Trial (Specialty Not Specified)) with Veteran's Health Administration;.

Suzanne Merrill, MD, FACS

has no relevant financial relationships to disclose at this time.

Chad Ritch, MD, MBA

has a financial relationship (Consultant or Advisor (Oncology)) with mIR Scientific;.

David Shin, MD

has a financial relationship (Meeting Participant or Lecturer (General Urology)) with Endo Pharmaceuticals;.
has a financial relationship (Investment Interest (Male Infertility)) with Fellow Health;.

Jay Simhan, MD,FACS

has a financial relationship (Meeting Participant or Lecturer (Specialty Not Specified)) with Coloplast;.
has a financial relationship (Meeting Participant or Lecturer (Specialty Not Specified)) with Boston Scientific ;.
has a financial relationship (Meeting Participant or Lecturer (Specialty Not Specified)) with Boston Scientific ;.
has a financial relationship (Meeting Participant or Lecturer (Specialty Not Specified)) with Coloplast;.

Kevan Sternberg, MD

has no relevant financial relationships to disclose at this time.

John Stoffel, MD

has a financial relationship (Leadership Position (Specialty Not Specified)) with Journal of urology;.

METHOD OF PARTICIPATION: 

Learners will participate in this online educational activity by taking the pretest, viewing the webcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 15.50 hours

Release Date: September, 2021
Expiration Date: September, 2024

CREDIT DESIGNATION: 

The American Urological Association designates this enduring material for a maximum of 15.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
Please login or register to take this course.